These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 24248326

  • 1. Multiple data sources, the best way to gather safety information about medications.
    Katz MH.
    JAMA Intern Med; 2014 Jan; 174(1):151. PubMed ID: 24248326
    [No Abstract] [Full Text] [Related]

  • 2. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    Sipahi I, Celik S, Tozun N.
    JAMA Intern Med; 2014 Jan 04; 174(1):150-1. PubMed ID: 24247291
    [No Abstract] [Full Text] [Related]

  • 4. Is there really misuse and abuse of dabigatran?
    Eikelboom JW, Hankey GJ.
    Med J Aust; 2013 Apr 15; 198(7):358-9. PubMed ID: 23581946
    [No Abstract] [Full Text] [Related]

  • 5. The trouble with dabigatran.
    Charlton B, Redberg R.
    BMJ; 2014 Jul 23; 349():g4681. PubMed ID: 25055830
    [No Abstract] [Full Text] [Related]

  • 6. Bleeding risk with dabigatran in the frail elderly.
    Harper P, Young L, Merriman E.
    N Engl J Med; 2012 Mar 01; 366(9):864-6. PubMed ID: 22375994
    [No Abstract] [Full Text] [Related]

  • 7. Dabigatran, bleeding, and the regulators.
    Moore TJ, Cohen MR, Mattison DR.
    BMJ; 2014 Jul 23; 349():g4517. PubMed ID: 25056265
    [No Abstract] [Full Text] [Related]

  • 8. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J, Pike G, Keighley-Jones L, Nash MJ.
    Am J Med; 2013 Aug 23; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract] [Full Text] [Related]

  • 9. Comment on ''gastrointestinal bleeding under dabigatran''.
    Gélisse P, Crespel A.
    J Postgrad Med; 2014 Aug 23; 60(4):413-4. PubMed ID: 25370556
    [No Abstract] [Full Text] [Related]

  • 10. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Aug 23; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 11. Risk of major bleeding and the standard doses of dabigatran.
    Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.
    Eur J Intern Med; 2014 Jul 23; 25(6):e73-5. PubMed ID: 24629895
    [No Abstract] [Full Text] [Related]

  • 12. [New oral anticoagulants and digestive hemorrhages].
    Diallo I, Mallaret C, Jourdan S, Brardjanian S, Guisset M, Coton T.
    Presse Med; 2014 Jan 23; 43(1):85-7. PubMed ID: 23706679
    [No Abstract] [Full Text] [Related]

  • 13. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J, Taskiran M.
    Ugeskr Laeger; 2013 Feb 04; 175(6):334-6. PubMed ID: 23402236
    [Abstract] [Full Text] [Related]

  • 14. Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
    Gunes F, Asik M, Temiz A, Binnetoglu E, Sen H, Bilen Oİ, Akbal E, Adam G, Ukinc K.
    Wien Klin Wochenschr; 2014 Jan 04; 126(1-2):62-3. PubMed ID: 24240609
    [No Abstract] [Full Text] [Related]

  • 15. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan 04; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 16. Concerns over data in key dabigatran trial.
    Cohen D.
    BMJ; 2014 Jul 23; 349():g4747. PubMed ID: 25055831
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of a dabigatran overdose: what are possible options?
    Ratanapo S, Ungprasert P, Srivali N, Cheungpasitporn W, Bischof EF.
    Am J Med Sci; 2013 Sep 23; 346(3):259. PubMed ID: 23974270
    [No Abstract] [Full Text] [Related]

  • 18. Dabigatran and bleeding: still an emergent situation?
    Van Heukelom J, Lal Y.
    Am J Med Sci; 2013 Sep 23; 346(3):259. PubMed ID: 23698156
    [No Abstract] [Full Text] [Related]

  • 19. [New anticoagulants, new emergencies?].
    Djalali S.
    Praxis (Bern 1994); 2013 Jul 24; 102(15):945-6. PubMed ID: 23876694
    [No Abstract] [Full Text] [Related]

  • 20. Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.
    Wong H, Keeling D.
    Br J Haematol; 2014 Jul 24; 166(1):152-3. PubMed ID: 24617554
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.